Jacobsen Biotech ApS: Financial statements 2023
CVR: 43211218
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Jacobsen Biotech ApS (CVR 43211218) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 4,000 and a net result of DKK -17,556. The profit margin was -438.9%. Equity in the 2023 report amounted to DKK 24,864. The solvency ratio was 100%.
- Revenue
- DKK 4,000
- Gross Profit
- DKK -14,568
- Profit/Loss
- DKK -17,556
- Equity
- DKK 24,864
- Total Assets
- DKK 24,864
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Jacobsen Biotech ApS has published its interim report for the period April 21, 2022 to December 31, 2022.
About Jacobsen Biotech ApS
Jacobsen Biotech ApS is a Danish company of the type Anpartsselskab based in Harlev J, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Kristian Mark Jacobsen. The company is owned by Kristian Mark Jacobsen. The company has 1 employee (2022). In 2025, the company reported a gross profit of DKK -7,890 and a net result of DKK -7,890 compared with DKK -2,872 the year before. Equity in the 2025 report amounted to DKK 14,103.